Search

Author/Creator Arias, L

2. DOP40 Comorbidities and epidemiological risk factor but not immunosuppressive therapies increase the risk of COVID-19 in Inflammatory Bowel Disease (IBD): An ENEIDA-based, case-control study. (27th May 2021)

Authors:
Zabana Abdo, Y; Marín-Jiménez, I; Rodríguez-Lago, I; Vera, I; Martín, M D; Guerra, I; Gisbert, J P; Mesonero, F; Benítez, O; Taxonera, C; Ponferrada-Díaz, Á; Piqueras, M; Lucendo, A; Caballol, B; Mañosa, M; Martínez-Montiel, P; Bosca-Watts, M; Gordillo, J; Bujanda, L; Manceñido, N
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S078
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. DOP78 Comparative study of the effectiveness of vedolizumab versus ustekinumab after anti-TNF failure (VERSUS-CD). (21st January 2022)

Authors:
García, M J; Rivero, M; Fernández-Clotet, A; de Francisco, R; Sicilia, B; Mesonero, F; de Castro, M L; Casanova, M J; Bertoletti, F; García Alonso, F J; López García, A; Julián, B; Calvet, X; Barreiro-de Acosta, M; Jara, L; Varela, P; Nuñez, A; Ricart, E; Riestra, S; Arias, L
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i121
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. OP20 Risk and predictors of surgery in a newly diagnosed cohort of IBD patients in the biologic era: Results from the EpidemIBD study. (27th May 2021)

Authors:
Chaparro, M; Garre, A; Núñez Ortiz, A; Diz-Lois Palomares, M T; Rodríguez, C; Riestra, S; Vela, M; Benítez, J M; Fernández Salgado, E; Sánchez Rodríguez, E; Hernández, V; Ferreiro-Iglesias, R; Ponferrada Díaz, Á; Barrio, J; Huguet, J M; Arias, L; Martín-Arranz, M D; Calvet, X; Ginard, D; Alonso-A...
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S018
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P122 Low Risk of new dysplastic lesions during inflammatory bowel disease surveillance with dye-cromoendoscopy: a multicenter population-based retrospective study. (21st January 2022)

Authors:
Saiz Chumillas, R M; Alba, L; Gonzalez-Lama, Y; Velayos, B; Suarez, P; Maroto-Martin, C; Nuñez, A; Hernandez, L; Relea, L; Fernandez-Salazar, L; Sierra-Ausin, M; Barrio, J; Muñoz, F; Arias, L; Sicilia, B
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i211
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P290 Therapeutic requirements in patients with Ulcerative Proctitis. Is it necessary immunosuppressive therapy in these patients?. (21st January 2022)

Authors:
Ferreiro Iglesias, R; Porto Silva, M S; Marín, S; Casanova, M J; Mañosa, M; González-Muñoza, C; de Francisco, R; Caballol, B; Arias, L; Piqueras, M; Zabana, Y; Rivero, M; Calvet, X; Mesonero, F; Varela Trastoy, P; Busta Nistal, R; Gomez Perosanz, R; Vega, P; Gonzalez Vivo, M; Iborra, M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i322
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. P433 Intravenous ustekinumab as maintenance treatment is effective in patients with partial or loss of response to optimized ustekinumab sc. (21st January 2022)

Authors:
Garcia-Alvarado, M; Barrio, J; Sierra-Ausin, M; Arias, L; Fernández-Salazar, L; Fuentes Coronel, A; Arias García, L; García-Alonso, F J; García-Prada, M; Legido, J; Sánchez-Hernández, J G; Muñoz, F
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i416
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗